시장보고서
상품코드
1957509

비호르몬 피임약 시장 보고서(2026년)

Non-Hormonal Contraceptives Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

비호르몬 피임약 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 254억 7,000만 달러에서 2026년에는 273억 2,000만 달러로, CAGR 7.3%로 성장할 것으로 예상됩니다. 지난 몇 년간의 성장에는 비호르몬 피임법의 접근성 제한, 외과적 불임 수술에 대한 의존도, 생식 건강에 대한 인식 증가, 여성 건강 관리 정책의 증가, 클리닉의 배리어 법 기기 도입 등이 요인으로 작용한 것으로 추정됩니다.

비호르몬 피임약 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 358억 달러에 달하고, CAGR은 7.0%를 기록할 전망입니다. 예측 기간 동안 성장 요인으로는 첨단 비호르몬 장치 개발, 가역적 최소침습적 불임 수술에 대한 수요 증가, 가족계획 프로그램 확대, 안전 및 준수 기준에 대한 인식 제고, 스마트 피임 모니터링 시스템 통합 등을 들 수 있습니다. 예측 기간의 주요 동향으로는 비호르몬 피임법에 대한 선호도 증가, 장벽법 및 기계식 피임기구의 보급 확대, 가역적 피임법에 대한 인식 개선, 최소침습적 피임기구의 확대, 안전성, 컴플라이언스, 환자 중심 설계에 대한 관심 증가 등이 있습니다.

성병의 확산 증가는 향후 몇 년 동안 비호르몬 피임약 시장의 성장을 촉진할 것으로 예상됩니다. 성병(STD)은 주로 성행위를 통해 감염되며 세균, 바이러스 또는 기생충에 의해 유발되는 감염성 질환입니다. 성병의 증가는 주로 콘돔 사용률의 감소와 관련이 있으며, 무방비 상태의 성행위로 인한 감염 위험을 증가시킵니다. 남성용 및 여성용 콘돔을 포함한 비호르몬 피임법은 체액 교환을 물리적으로 차단하는 장벽 역할을함으로써 성병의 확산을 방지하는 데 기여합니다. 예를 들어, 미국 미네소타주 보건국(MDH)이 2025년 4월 발표한 자료에 따르면, 35-39세 남성의 HIV 감염자 비율이 2023년 10%에서 2024년 17%로 상승했습니다. 이는 성병의 확산이 비호르몬 피임약 시장의 성장을 촉진하고 있음을 보여줍니다.

비호르몬 피임약 시장의 주요 기업들은 삽입을 간소화하고, 사용자 편의성을 높이고, 임상 효율성을 개선하기 위해 사전 장착된 자궁 내 장치(IUD) 삽입 시스템과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 사전 로드된 IUD 삽입 시스템은 IUD와 삽입기를 하나의 장치에 통합한 즉시 사용 가능한 장치로, 삽입을 효율화하고 설정 시간을 단축하며 오염 및 취급 오류를 최소화합니다. 예를 들어, 2024년 9월, 미국에 본사를 둔 의료기기 및 불임 치료 기업 쿠퍼 서지컬(Cooper Surgical)은 비호르몬 IUD 삽입 시 삽입 효율과 환자의 편안함을 개선하기 위해 파라가드 싱글 핸드 인서트(Paragard Single Hand Insertor)를 발표했습니다. 이 장치는 99% 이상의 피임 효과를 자랑하며, 최대 10년간의 장기 피임이 가능하고, 최소한의 유지관리로 즉각적이고 가역적이며 호르몬을 사용하지 않는 피임 수단을 제공합니다.

자주 묻는 질문

  • 비호르몬 피임약 시장 규모는 어떻게 변화하고 있나요?
  • 비호르몬 피임약 시장의 성장 요인은 무엇인가요?
  • 성병의 확산이 비호르몬 피임약 시장에 미치는 영향은 무엇인가요?
  • 비호르몬 피임약 시장의 주요 기업들은 어떤 혁신을 추구하고 있나요?
  • 비호르몬 피임약의 주요 동향은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM

Non-hormonal contraceptives are methods of preventing pregnancy that do not rely on hormones to alter a woman's reproductive system. They work through physical barriers, chemical agents, or natural tracking methods, allowing individuals to prevent pregnancy without affecting the body's hormonal balance.

The main types of non-hormonal contraceptives include devices, sterilization, and others. Devices are physical tools, instruments, or equipment designed to perform specific functions, often used in medical, industrial, or consumer applications. Their mechanisms of action may involve functioning as antagonists, agonists, inhibitors, or modulators. These products can be administered through various routes, such as intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal, and others. They are intended for both disease treatment and symptom management. Target indications for these contraceptives include bacterial vaginosis, contraception, endometriosis, postmenopausal osteoporosis, uterine fibroids, vaginitis, and more.

Tariffs have affected the non-hormonal contraceptives market by increasing the cost of imported medical devices and surgical instruments, particularly affecting barrier devices, tubal rings, and implantable plugs. Asia-Pacific regions such as India and China are most impacted due to high import duties on manufacturing equipment and components. While tariffs have raised production costs and slowed supply chain efficiency, they also promote domestic manufacturing, encourage innovation in device design, and create opportunities for local suppliers to expand.

The non-hormonal contraceptives market research report is one of a series of new reports from The Business Research Company that provides non-hormonal contraceptives market statistics, including non-hormonal contraceptives industry global market size, regional shares, competitors with a non-hormonal contraceptives market share, detailed non-hormonal contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the non-hormonal contraceptives industry. This non-hormonal contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-hormonal contraceptives market size has grown strongly in recent years. It will grow from $25.47 billion in 2025 to $27.32 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to limited availability of non-hormonal contraceptive methods, reliance on surgical sterilization, growing awareness of reproductive health, increasing female healthcare initiatives, adoption of barrier devices in clinics.

The non-hormonal contraceptives market size is expected to see strong growth in the next few years. It will grow to $35.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to development of advanced non-hormonal devices, rising demand for reversible and minimally invasive sterilization, expansion of family planning programs, increasing awareness of safety and compliance standards, integration of smart contraceptive monitoring systems. Major trends in the forecast period include rising preference for non-hormonal contraceptive methods, growing adoption of barrier and mechanical devices, increasing awareness about reversible sterilization options, expansion of minimally invasive contraceptive devices, focus on safety, compliance, and patient-centric design.

The rising prevalence of sexually transmitted diseases is expected to drive growth in the non-hormonal contraceptives market in the coming years. Sexually transmitted diseases (STDs) are infections primarily spread through sexual contact and caused by bacteria, viruses, or parasites. The increase in STDs is largely linked to decreased condom usage, which raises the risk of infection during unprotected sexual activity. Non-hormonal contraceptives, including male and female condoms, help prevent the spread of STDs by acting as a physical barrier that blocks the exchange of bodily fluids. For example, in April 2025, the Minnesota Department of Health (MDH), a U.S.-based state health agency, reported that the proportion of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024. This indicates that the growing prevalence of STDs is fueling growth in the non-hormonal contraceptives market.

Key companies in the non-hormonal contraceptives market are focusing on developing innovative solutions, such as preloaded intrauterine device (IUD) delivery systems, to simplify insertion, enhance user convenience, and improve clinical efficiency. A preloaded IUD delivery system is a ready-to-use device that integrates the IUD and inserter into a single unit, streamlining insertion, reducing setup time, and minimizing contamination or handling errors. For instance, in September 2024, CooperSurgical Inc., a U.S.-based medical device and fertility company, introduced the Paragard Single-Handed Inserter to improve insertion efficiency and patient comfort during non-hormonal IUD placement. The device provides over 99% effective, long-term contraception for up to 10 years, offering immediate, reversible, hormone-free birth control with minimal maintenance.

In November 2023, Dare Bioscience Inc., a U.S.-based biopharmaceutical company, partnered with Premier Research International LLC to extend their collaboration and support the clinical development of Dare's women's health programs. This partnership aims to accelerate clinical timelines, improve study execution through expanded operational support, enhance trial management efficiency, and advance novel women's health candidates toward regulatory milestones. Premier Research International LLC is a U.S.-based clinical research organization providing full-service development support for biotechnology and medical technology companies.

Major companies operating in the non-hormonal contraceptives market are Church & Dwight Co., Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, Contraline Inc.

North America was the largest region in the non-hormonal contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-hormonal contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-hormonal contraceptives market consists of sales of male condoms, copper intrauterine devices (IUDs), diaphragms, cervical caps, and spermicides. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Hormonal Contraceptives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses non-hormonal contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-hormonal contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-hormonal contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Devices; Sterilization; Other Product Types
  • 2) By Mechanism Of Action: Antagonist; Agonist; Inhibitor; Modulator
  • 3) By Route of Administration: Intramuscular; Intravaginal; Intravenous; Oral; Subcutaneous; Topical; Transdermal; Other Route Of Administrations
  • 4) By Purpose Of Therapy: Treatment Of Disease; Management Of Symptoms
  • 5) By Target Indication: Bacterial Vaginosis; Contraception; Endometriosis; Postmenopausal Osteoporosis; Uterine Fibroids; Vaginitis; Other Target Indications
  • Subsegments:
  • 1) By Devices: Surgical Instruments; Ligation Clips; Tubal Rings
  • 2) By Sterilization: Permanent Sterilization; Reversible Sterilization; Mechanical Sterilization Devices
  • 3) By Other Product Types: Non-Surgical Barrier Devices; Implantable Plugs; Intrauterine Permanent Devices
  • Companies Mentioned: Church & Dwight Co.; Okamoto Industries; CooperSurgical Inc.; PSI India Pvt Ltd.; Karex Berhad; Fuji Latex Co. Ltd.; PREGNA INTERNATIONAL LTD.; Cupid Limited; Global Protection Corp.; SMB Corporation of India; HLL Lifecare Limited; Contraline Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Non-Hormonal Contraceptives Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Non-Hormonal Contraceptives Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Non-Hormonal Contraceptives Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Non-Hormonal Contraceptives Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Rising Preference For Non-Hormonal Contraceptive Methods
    • 4.2.2 Growing Adoption Of Barrier And Mechanical Devices
    • 4.2.3 Increasing Awareness About Reversible Sterilization Options
    • 4.2.4 Expansion Of Minimally Invasive Contraceptive Devices
    • 4.2.5 Focus On Safety, Compliance, And Patient-Centric Design

5. Non-Hormonal Contraceptives Market Analysis Of End Use Industries

  • 5.1 Healthcare Providers
  • 5.2 Hospitals And Clinics
  • 5.3 Reproductive Health Centers
  • 5.4 Family Planning Organizations
  • 5.5 Medical Research Institutions

6. Non-Hormonal Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Hormonal Contraceptives Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Non-Hormonal Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Non-Hormonal Contraceptives Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Non-Hormonal Contraceptives Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Non-Hormonal Contraceptives Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Hormonal Contraceptives Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Hormonal Contraceptives Market Segmentation

  • 9.1. Global Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Devices, Sterilization, Other Product Types
  • 9.2. Global Non-Hormonal Contraceptives Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antagonist, Agonist, Inhibitor, Modulator
  • 9.3. Global Non-Hormonal Contraceptives Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intramuscular, Intravaginal, Intravenous, Oral, Subcutaneous, Topical, Transdermal, Other Route Of Administrations
  • 9.4. Global Non-Hormonal Contraceptives Market, Segmentation By Purpose Of Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Treatment Of Disease, Management Of Symptoms
  • 9.5. Global Non-Hormonal Contraceptives Market, Segmentation By Target Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis, Other Target Indications
  • 9.6. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Instruments, Ligation Clips, Tubal Rings
  • 9.7. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Sterilization, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Permanent Sterilization, Reversible Sterilization, Mechanical Sterilization Devices
  • 9.8. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Surgical Barrier Devices, Implantable Plugs, Intrauterine Permanent Devices

10. Non-Hormonal Contraceptives Market Regional And Country Analysis

  • 10.1. Global Non-Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Non-Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Hormonal Contraceptives Market

  • 11.1. Asia-Pacific Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Hormonal Contraceptives Market

  • 12.1. China Non-Hormonal Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Hormonal Contraceptives Market

  • 13.1. India Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Hormonal Contraceptives Market

  • 14.1. Japan Non-Hormonal Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Hormonal Contraceptives Market

  • 15.1. Australia Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Hormonal Contraceptives Market

  • 16.1. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Hormonal Contraceptives Market

  • 17.1. South Korea Non-Hormonal Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Hormonal Contraceptives Market

  • 18.1. Taiwan Non-Hormonal Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Hormonal Contraceptives Market

  • 19.1. South East Asia Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Hormonal Contraceptives Market

  • 20.1. Western Europe Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Hormonal Contraceptives Market

  • 21.1. UK Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Hormonal Contraceptives Market

  • 22.1. Germany Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Hormonal Contraceptives Market

  • 23.1. France Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Hormonal Contraceptives Market

  • 24.1. Italy Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Hormonal Contraceptives Market

  • 25.1. Spain Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Hormonal Contraceptives Market

  • 26.1. Eastern Europe Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Hormonal Contraceptives Market

  • 27.1. Russia Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Hormonal Contraceptives Market

  • 28.1. North America Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Hormonal Contraceptives Market

  • 29.1. USA Non-Hormonal Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Hormonal Contraceptives Market

  • 30.1. Canada Non-Hormonal Contraceptives Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Hormonal Contraceptives Market

  • 31.1. South America Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Hormonal Contraceptives Market

  • 32.1. Brazil Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Hormonal Contraceptives Market

  • 33.1. Middle East Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Hormonal Contraceptives Market

  • 34.1. Africa Non-Hormonal Contraceptives Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Non-Hormonal Contraceptives Market, Segmentation By Type, Segmentation By Mechanism Of Action, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Hormonal Contraceptives Market Regulatory and Investment Landscape

36. Non-Hormonal Contraceptives Market Competitive Landscape And Company Profiles

  • 36.1. Non-Hormonal Contraceptives Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Non-Hormonal Contraceptives Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Non-Hormonal Contraceptives Market Company Profiles
    • 36.3.1. Church & Dwight Co. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Okamoto Industries Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. CooperSurgical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. PSI India Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Karex Berhad Overview, Products and Services, Strategy and Financial Analysis

37. Non-Hormonal Contraceptives Market Other Major And Innovative Companies

  • Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, Contraline Inc.

38. Global Non-Hormonal Contraceptives Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Hormonal Contraceptives Market

40. Non-Hormonal Contraceptives Market High Potential Countries, Segments and Strategies

  • 40.1 Non-Hormonal Contraceptives Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Non-Hormonal Contraceptives Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Non-Hormonal Contraceptives Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제